Organon OGN
NYSE OGN
$13.75 +0.01 (+0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Organon (OGN) Cash from Discontinued Operations (2020 - 2021)

Organon (OGN) posted quarterly Cash from Discontinued Operations of 94000000.0 for Q2 2021, up 34.29% year-over-year from 70000000.0 in Q2 2020, and down 53.92% on a QoQ basis from 204000000.0 in Q1 2021.

Organon (OGN) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends

Organon has reported Cash from Discontinued Operations for 2 years, with the latest figure at 94000000.0 in Q2 2021.

  • Cash from Discontinued Operations for Q2 2021 came in at 94000000.0, up 34.29% year-over-year; the trailing twelve-month figure through Mar 2022 was 94000000.0 (down 50.0% YoY), and the FY2021 annual result was 298000000.0, up 407.22% from the prior year.
  • Cash from Discontinued Operations slipped to 94000000.0 in Q2 2021, from 204000000.0 in the prior quarter.
  • Over five years, Cash from Discontinued Operations peaked at 204000000.0 in Q1 2021 and troughed at 81000000.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 3.61 Bn
10 Organon 3.61 Bn 2.48 Bn 847.00 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 94.00 Mn
Jun 30, 2021 94.00 Mn
Mar 31, 2021 204.00 Mn
Mar 31, 2021 204.00 Mn
Dec 31, 2020 -54.00 Mn
Dec 31, 2020 -54.00 Mn
Sep 30, 2020 -32.00 Mn
Sep 30, 2020 -32.00 Mn
Jun 30, 2020 70.00 Mn
Jun 30, 2020 70.00 Mn
Mar 31, 2020 -81.00 Mn
Mar 31, 2020 -81.00 Mn